Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
Cumberland and Sampson counties are under alert.
Program
On WRAL at 6: Stolen truck from a valet lot! 5 On Your Side tracks whoâs liable and the disturbing allegations.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
231.55
-0.27 (-0.12%)
Streaming Delayed Price
Updated: 3:14 PM EDT, Jul 1, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Why Sage Lost Half Its Value After The FDA Approved Its Depression Drug
August 07, 2023
The company gained approval for the first oral treatment for postpartum depression.
Via
Investor's Business Daily
FDA Approves Sage Therapeutics/Biogen's Zuranolone For One Type Of Depression, Rejects For Another
August 07, 2023
The FDA approved Sage Therapeutics Inc (NASDAQ: SAGE) and Biogen Inc's (NASDAQ: BIIB) Zurzuvae (zuranolone) 50 mg for adults with
Via
Benzinga
Biogen Unusual Options Activity For August 02
August 02, 2023
Via
Benzinga
3 ‘Strong Buy’ Biotech Stocks You Should Be Loading Up On Now
August 02, 2023
Biotech stocks can be a lucrative investment opportunity, these three biotech stocks to buy now are among analyst favorites.
Via
InvestorPlace
Buy Alert: 3 Biotech Stocks Nearing Super Attractive Entry Points
August 01, 2023
Investors looking to give their portfolio a boost should consider one of these leading biotech names, which are undervalued right now.
Via
InvestorPlace
Biogen's Just Made Its Biggest Acquisition. Here's What You Need to Know.
August 01, 2023
Biogen also recently announced a plan to cut costs and focus investment on high-growth areas.
Via
The Motley Fool
Here's How Much You Would Have Made Owning Biogen Stock In The Last 15 Years
July 31, 2023
Via
Benzinga
Health Care Company Biogen Announces Acquisition of Reata Pharmaceuticals
July 28, 2023
Via
Benzinga
I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO
July 27, 2023
Biogen shares have stagnated in recent years, but the company has a plan to change that.
Via
The Motley Fool
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers
July 31, 2023
Via
Benzinga
Better Alzheimer's Drug Stock: Eli Lilly vs. Biogen
July 31, 2023
By 2024, their medicines will likely be competing on the market, and one might win.
Via
The Motley Fool
Analyst Ratings for Biogen
July 26, 2023
Via
Benzinga
Biogen (BIIB) Q2 2023 Earnings Call Transcript
July 25, 2023
BIIB earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Could This Stock Be the Next Biotech Buyout?
July 31, 2023
A buyout deal recently pushed Reata Pharmaceuticals stock 53% higher in a single trading session, leading investors to wonder who's next.
Via
The Motley Fool
3 Millionaire-Maker Biotech Stocks to Buy Before the Window Closes
July 30, 2023
Here are three millionaire maker drug stocks from companies whose drugs could make truly staggering profits.
Via
InvestorPlace
Biotech Battlefields: 3 Stocks to Watch Amid Wall Street Turmoil
July 29, 2023
There is opportunity in a crisis. Key biotech stocks amid turmoil could be the greatest deals on the market today.
Via
InvestorPlace
Reata's Acquisition Fits Biogen's Strategy Despite High Cost: Analyst Says High Level Regulatory Scrutiny Not Anticipated
July 28, 2023
Earlier today, Biogen Inc (NASDAQ: BIIB) agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of
Via
Benzinga
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
July 28, 2023
Reata Pharmaceuticals (RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (BIIB).
Via
InvestorPlace
Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review
July 28, 2023
Despite Thursday's downside reversal, the major indexes had a solid advance.
Via
Investor's Business Daily
Biogen Announces $7.3 Billion Acquisition Of Reata Pharmaceuticals
July 28, 2023
Reata stock surged more than 50% on the news.
Via
Investor's Business Daily
Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B
July 28, 2023
Biogen Inc (NASDAQ: BIIB) has agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
July 27, 2023
Via
Benzinga
Neuroinflammation A Key Indicator For Alzheimer’s, But Current Treatments Show Little Success In Reducing Or Even Increase It — Could This Rising Company Have The Answer?
July 27, 2023
--News Direct--
Via
News Direct
Exposures
Product Safety
Why Sage Therapeutics Stock Is Tumbling Today
July 26, 2023
A partner's perceived lack of enthusiasm for an upcoming regulatory decision is spooking investors today.
Via
The Motley Fool
Why Biogen Stock Got Sick Today
July 25, 2023
While the company has won approval for a promising drug, it's cutting costs in the wake of that regulatory green light.
Via
The Motley Fool
Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event, TikTok Takes On Twitter, Analysts Expect Nvidia's AI Revenues To Reach $300B In Five Years: Today's Top Stories
July 25, 2023
The Hill Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event
Via
Benzinga
WMT Stock Alert: Is Walmart Really Worth $210?
July 25, 2023
Walmart (WMT) stock is in the news Tuesday as investors react to the latest coverage from Piper Sandler analyst Edward Yruma.
Via
InvestorPlace
MBLY Stock Alert: Morgan Stanley Restarts Mobileye Coverage
July 25, 2023
Mobileye (MBLY) stock is on the move Tuesday after Morgan Stanley analyst Adam Jonas renewed coverage of the company's shares.
Via
InvestorPlace
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
July 25, 2023
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
Via
InvestorPlace
Biogen Q2 Earnings Tops Expectations, Shift Resources To Higher Value Area(s), Layoff 1K Staff
July 25, 2023
Biogen Inc (NASDAQ: BIIB) posted Q2 FY23 sales of $2.46 billion, beating the con
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
38
39
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.